Masked hypertension (MHT), defined as nonelevated blood pressure (BP) in the clinic setting and elevated BP assessed by ambulatory monitoring, is associated with increased risk of target organ damage, cardiovascular disease, and mortality. Currently, no estimate of MHT prevalence exists for the general US population. After pooling data from the Masked Hypertension Study (n = 811), a cross-sectional clinical investigation of systematic differences between clinic BP and ambulatory BP (ABP) in a community sample of employed adults in the New York City metropolitan area (2005–2012), and the National Health and Nutrition Examination Survey (NHANES;

https://ainolehti.tumblr.com/

2005–2010; n = 9,316), an ongoing nationally representative US survey, we used multiple imputation to impute ABP-defined hypertension status for NHANES participants and estimate MHT prevalence among the 139 million US adults with nonelevated clinic BP, no history of overt cardiovascular disease, and no use of antihypertensive medication. The estimated US prevalence of MHT in 2005–2010 was 12.3% of the adult population (95% confidence interval: 10.0, 14.5)—approximately 17.1 million persons aged ?21 years.

https://catamari.tumblr.com/

Consistent with prior research, estimated MHT prevalence was higher among older persons, males, and those with prehypertension or diabetes. To our knowledge, this study provides the first estimate of US MHT prevalence—nearly 1 in 8 adults with nonelevated clinic BP—and suggests that millions of US adults may be misclassified as not having hypertension. Source: https://academic.oup.com/aje/article-abstract/185/3/194/2915788/Prevalence-of-Masked-Hypertension-Among-US-Adults

Tuesday, May 12, 2026

Aricept For Depression: Benefits, Dosage, And Safety

When a person is diagnosed with depression or seeks relief from it, selecting the most appropriate medication requires weighing multiple factors: the severity of symptoms, the patient's age and health history, and whether other medications are already being taken. A thoughtful treatment choice improves outcomes and reduces unnecessary side effects. Dementia refers broadly to a group of symptoms associated with a decline in cognitive function severe enough to interfere with daily life. Alzheimer's disease typically begins with subtle short-term memory difficulties and progresses over years to affect language, abstract reasoning, spatial orientation, and behavior. The rate of progression varies considerably between individuals. Early diagnosis allows patients and families time to plan for future care needs and access treatments that may slow cognitive decline. Among the medications available for Alzheimer's disease and dementia care, Aricept provides a well-studied option that many patients discuss with their doctors. The clinical evidence supporting aricept for depression shows that it can be effective for managing this condition when used appropriately under medical supervision. Aricept contains the active ingredient donepezil, which works by acting on the biological pathways responsible for producing the symptoms associated with depression. Understanding the mechanism helps patients appreciate why consistent use is often more effective than taking it only when symptoms become severe, as maintaining steady levels allows for more stable control. Patients managing depression long-term should keep regular follow-up appointments to assess whether their treatment plan is still the best fit for their situation. As conditions change and new evidence emerges, treatment adjustments may be worthwhile. The Alzheimer's disease and dementia care resource section provides a helpful reference for staying current on medication options in this area.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.